Teriparatide Patent Expiration
Teriparatide is used for reducing the risk of bone fractures in post-menopausal women with osteoporosis. It was first introduced by Eli Lilly And Co
Teriparatide Patents
Given below is the list of patents protecting Teriparatide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Forteo | US6770623 | Stabilized teriparatide solutions |
Dec 08, 2018
(Expired) | Lilly |
| Forteo | US6977077 | Method of increasing bone toughness and stiffness and reducing fractures |
Aug 19, 2019
(Expired) | Lilly |
| Forteo | US7144861 | Stabilized teriparatide solutions |
Dec 08, 2018
(Expired) | Lilly |
| Forteo | US7163684 | Method of increasing bone toughness and stiffness and reducing fractures |
Aug 19, 2019
(Expired) | Lilly |
| Forteo | US7351414 | Method of reducing the risk of bone fracture |
Aug 19, 2019
(Expired) | Lilly |
| Forteo | US7517334 | Medication dispensing apparatus with spring-driven locking feature enabled by administration of final dose | Mar 25, 2025 | Lilly |
| Forteo | US7550434 | Stabilized teriparatide solutions |
Dec 08, 2018
(Expired) | Lilly |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Teriparatide Generics
Several generic applications have been filed for Teriparatide. The first generic version for Teriparatide was by Teva Pharmaceuticals Usa Inc and was approved on Nov 16, 2023. And the latest generic version is by Apotex Inc and was approved on Nov 16, 2023.
Given below is the list of companies who have filed for Teriparatide generic.
1. APOTEX
Apotex Inc has filed for 1 generic for Teriparatide. Given below are the details of the strengths of this generic introduced by Apotex.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.6MG/2.4ML (0.25MG/ML) | solution | Prescription | SUBCUTANEOUS | AP | Nov 16, 2023 |
2. TEVA PHARMS USA
Teva Pharmaceuticals Usa Inc has filed for 1 generic for Teriparatide. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.6MG/2.4ML (0.25MG/ML) | solution | Prescription | SUBCUTANEOUS | AP | Nov 16, 2023 |